CAS 1480-19-9

Fluanisone

Description:

Fluanisone is a synthetic antipsychotic medication primarily used in the treatment of schizophrenia and other psychotic disorders. It belongs to the class of compounds known as butyrophenones, which are characterized by their ability to block dopamine receptors in the brain, thereby helping to alleviate symptoms of psychosis. Fluanisone is known for its sedative properties and is often utilized in combination with other medications to enhance therapeutic effects. The substance is typically administered via intramuscular injection, providing a long-acting formulation that can be beneficial for patients who may have difficulty adhering to oral medication regimens. In terms of its chemical structure, Fluanisone features a fluorinated phenyl ring, which contributes to its pharmacological activity. As with many antipsychotic medications, potential side effects may include sedation, extrapyramidal symptoms, and metabolic changes, necessitating careful monitoring during treatment. Overall, Fluanisone represents an important option in the pharmacological management of severe psychiatric conditions.

Formula: C₂₁H₂₅FN₂O₂

InChI: InChI=1/C21H25FN2O2/c1-26-21-7-3-2-5-19(21)24-15-13-23(14-16-24)12-4-6-20(25)17-8-10-18(22)11-9-17/h2-3,5,7-11H,4,6,12-16H2,1H3

InChI key: InChIKey=IRYFCWPNDIUQOW-UHFFFAOYSA-N

SMILES: O(C)C1=C(C=CC=C1)N2CCN(CCCC(=O)C3=CC=C(F)C=C3)CC2

Synonyms:

• 1-(4-Fluorophenyl)-4-[4-(2-methoxyphenyl)-1-piperazinyl]-1-butanone
• 1-(4-Fluorophenyl)-4-[4-(2-methoxyphenyl)piperazin-1-yl]butan-1-one
• 1-Butanone, 1-(4-Fluorophenyl)-4-[4-(2-Methoxyphenyl)-1-Piperazinyl]-
• 1480-19-9
• 2028 Md
• 216-038-8
• 4'-Fluoro-4-[4-(o-methoxyphenyl)-1-piperazinyl]butyrophenone
• 4-[4-(o-Methoxyphenyl)-1-piperazinyl]-p-fluorobutyrophenone
• Anti-Pica
• Butyrophenone, 4'-fluoro-4-[4- (o-methoxyphenyl)-1-piperazinyl]-
• Fluanison
• Haloanison
• Haloanisone
• Md 2028
• NSC 170977
• R 2028
• R 2167
• Sedalande
• p-Fluoro-γ-[4-(o-methoxyphenyl)-1-piperazinyl]butyrophenone
• γ-(4-o-Methoxyphenylpiperazino)-4-fluorobutyrophenone
• Fluanisone
• Flusnisone
• Fluanisone USP/EP/BP

Fluanisone

CAS: 1480-19-9

Color and Shape: Neat

Ref: 61-FOR1247.00

Fluanisone

CAS: 1480-19-9

Fluanisone

Purity: ≥98%

Molecular weight: 356.43g/mol

Ref: 54-BUP13877

Fluanisone

CAS: 1480-19-9

Color and Shape: Neat

Ref: 04-C13667500

Fluanisone

Controlled Product

CAS: 1480-19-9

Formula: C₂₁H₂₅FN₂O₂

Color and Shape: Neat

Molecular weight: 356.43

Ref: 86-MM1247.00

Fluanisone

CAS: 1480-19-9

Fluanisone (Haloanison) is a butyrophenone derivative with sedative properties. It is a typical antipsychotic and is used in the treatment of schizophrenia.

Formula: C₂₁H₂₅FN₂O₂

Purity: 99.94%

Color and Shape: Solid

Molecular weight: 356.43

Ref: TM-T4275

Fluanisone-d8

CAS: 1480-19-9

Formula: C₂₁H₁₇FN₂O₂D₈

Molecular weight: 364.49

Ref: 4Z-F-632

Fluanisone

CAS: 1480-19-9

Formula: C₂₁H₂₅FN₂O₂

Molecular weight: 356,44

Ref: 4Z-F-631

Fluanisone

CAS: 1480-19-9

Fluanisone is a fatty acid with anti-inflammatory properties that has been shown to inhibit the production of inflammatory cytokines, such as TNF-α and IL-1β. Fluanisone has also been found to have an analgesic effect on animals anesthetized with isoflurane. The compound binds to κ-opioid receptors in the brain, leading to a decrease in the release of neurotransmitters such as dopamine and glutamate. Fluanisone has also been shown to stimulate the release of growth factors from cells in culture. This effect may be due to its ability to inhibit Toll-like receptor 4, which plays a role in inflammation.

Formula: C₂₁H₂₅FN₂O₂

Purity: Min. 95%

Color and Shape: White Powder

Molecular weight: 356.43 g/mol

Ref: 3D-FF23312